EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer

Bo-Guen Kim, Kyunghee Park iD, Mina Hwang, Hyewon Lee, Kyung-Mi Park, Junsu Choe, Sun Hye Shin, Byeong-Ho Jeong, Kyungjong Lee, Junghee Lee, Yeong Jeong Jeon, Jong Ho Cho und 3 weitere

Cancers · 30.08.2025 · 17 (17) · 2858

DOI: 10.3390/cancers17172858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 30.08.2025. Verfasst von Bo-Guen Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 0…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cancer-associated fibroblasts (CAFs) play a pivotal role in the tumor microenvironment. We conducted an analysis using RNA sequencing to identify specific markers for CAFs compared to normal fibroblasts (NFs) in non-small-cell carcinoma (NSCLC).

Methods

CAFs and NFs were isolated and cultured from tumor tissues (primary tumor or metastatic lymph nodes) and matched non-tumor tissues, respectively. Bulk RNA sequencing was conducted on isolated CAFs and normal fibroblast NFs. Differential expressions, gene set enrichment, and CAF subpopulation prediction analyses were performed.

Results

During the study period, 27 CAFs and 12 NFs were isolated and cultured from tumor and non-tumor tissues in patients with treatment-naïve NSCLC. Among them, 22 CAFs and 11 NFs were included in the RNA sequencing analysis. The 22 CAF samples consisted of 12 adenocarcinomas and 10 squamous cell carcinomas (SqCC), with 16 samples from the lungs and 6 samples from the lymph nodes. Notably, COL11A1, GREM1, CD36, and GAS6 showed a higher expression in CAFs than in NFs, whereas TNC and CXCL2 were more abundantly expressed in NFs. CD36 levels were elevated in CAFs from lymph nodes (LN-CAFs) compared with those from lung specimens (Lung-CAFs) and NFs. COL11A1 levels in Lung-CAFs surpassed those in LN-CAFs and NFs. Both GREM1 and GAS6 showed a strong expression in Lung-CAFs and LN-CAFs relative to NFs. CAFs exhibited features of the myofibroblast CAF subpopulation, whereas NFs displayed traits of the antigen-presenting CAF subtype. In the co-culture model of CAFs and THP-1 cells, the knockdown of GREM1 or GAS6 in CAFs significantly decreased the M2 marker expression in macrophages.

Conclusions

In NSCLC, GREM1 and GAS6 can be valuable diagnostic targets for CAFs from primary tumors and metastatic sites; they warrant further study.

Schlagwörter

Stichwörter der Autor:innen

cancer-associated fibroblastlunglymph nodenon-small cell carcinoma

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Division of Pulmonary Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
  • Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Republic of Korea.
  • Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
  • Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea.

ORCID-Profile: Kyunghee Park, Woong-Yang Park, Sang-Won Um

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, B. G., Park, K., Hwang, M., Lee, H., Park, K. M., Choe, J., Shin, S. H., Jeong, B. H., Lee, K., Lee, J., Jeon, Y. J., Cho, J. H., Kim, H. K., Park, W. Y., & Um, S. W. (2025). Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. Cancers, 17(17), 2858. https://doi.org/10.3390/cancers17172858

Vancouver

Kim BG, Park K, Hwang M, Lee H, Park KM, Choe J, et al. Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer. Cancers. 2025;17(17):2858. doi:10.3390/cancers17172858

BibTeX
@article{Kim2025,
  author = {Kim, Bo-Guen and Park, Kyunghee and Hwang, Mina and Lee, Hyewon and Park, Kyung-Mi and Choe, Junsu and Shin, Sun Hye and Jeong, Byeong-Ho and Lee, Kyungjong and Lee, Junghee and Jeon, Yeong Jeong and Cho, Jong Ho and Kim, Hong Kwan and Park, Woong-Yang and Um, Sang-Won},
  title = {Identification of GREM-1 and GAS6 as Specific Biomarkers for Cancer-Associated Fibroblasts Derived from Patients with Non-Small-Cell Lung Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {17},
  pages = {2858},
  doi = {10.3390/cancers17172858}
}
Kostenlos starten →